Show document

A+ | A- | | SLO | ENG

Title: Presejalni program ZORA po petih letih delovanja že kaže pomembne javnozdravstvene rezultate Authors: ID Primic-Žakelj, Maja (Author) ID Pogačnik, Ana (Author) ID Uršič-Vrščaj, Marjetka (Author) ID Ivanuš, Urška (Author) Files: PDF - Presentation file, download (49,05 KB) MD5: D194904DA25B56B9C8EF459258A426F0 PID: 20.500.12556/dirros/a0c7bedf-a07b-4331-a34c-796dbd1edb25   Language: Slovenian Typology: 1.04 - Professional Article Organization: OI - Institute of Oncology Abstract: Program ZORA po petih letih delovanja na državni ravni že kaže javnozdravstvene rezultate. Prvi je velika pregledanost žensk, torej odstotni delež žensk, starih 20–64 let, ki so v treh letih, kolikor je priporočeni interval med presejalnimi pregledi, opravile vsaj en pregled brisa materničnega vratu. V zadnjem obdobju (2006–2008) je stopnja pregledanosti pri nas 71,2-odstotna. Če preračunamo pregledanost na pet let, kot je presejalni interval na Finskem in v Veliki Britaniji, torej v državah, ki so drugim v Evropi zgled, je pri nas ta stopnja 82,1-odstotna. V Veliki Britaniji je bila v istem obdobju 78,6- odstotna, na Finskem pa že dolga leta ne presega 70 %. Drugi je manjše število novih primerov raka materničnega vratu (incidenca raka materničnega vratu). Incidenca raka materničnega vratu se je v petih letih delovanja presejalnega programa zmanjšala za dobro četrtino (28 %), z 209 novih primerov leta 2003 na 151 novih primerov leta 2007. Podatki Registra ZORA kažejo, da je bilo v letu 2007 pri 235.713 ženskah odvzetih in pregledanih 260.684 brisov. Na presejalnem pregledu je bilo 194.163 žensk (82 %), druge so prišle na kontrolni pregled ali pa so imele klinične težave. V registru histoloških izvidov je bilo registriranih 8.569 izvidov, skoraj dve tretjini (nekaj več kot polovico) je rezultat diagnostičnih posegov. Dobrih rezultatov zagotovo ne bi bilo mogoče doseči brez prizadevanja številnih ginekologov v primarnem zdravstvenem varstvu žensk, presejalcev in citopatologov v laboratorijih in vseh drugih strokovnjakov, ki sodelujejo v multidisciplinarnem postopku presejanja in zdravljenja predrakavih in rakavih sprememb materničnega vratu. Želimo si, da bi skupna prizadevanja dajala podobne, če ne še boljše rezultate tudi v prihodnje. Publication status: Published Publication version: Version of Record Year of publishing: 2009 Number of pages: str. 4-6 Numbering: Letn. 13, št. 1 PID: 20.500.12556/DiRROS-8889  UDC: 616-006 ISSN on article: 1408-1741 URN: URN:NBN:SI:doc-P8GOVDA7 COBISS.SI-ID: 25688281  Copyright: by Authors Note: BSDOCID145196; Publication date in DiRROS: 31.08.2018 Views: 3133 Downloads: 821 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:	Onkologija
Shortened title:	Onkologija
Publisher:	Onkološki inštitut
ISSN:	1408-1741
COBISS.SI-ID:	65324032

Licences

License:	CC BY 4.0, Creative Commons Attribution 4.0 International
Link:	http://creativecommons.org/licenses/by/4.0/
Description:	This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:	31.08.2018

Secondary language

Language:	English
Title:	Cervical Cancer Screening Programe »ZORA« after five years of introduction at National Level Shows Good Public Health Results
Abstract:	Five years after the introduction of the cervical cancer screening program organized in Slovenia at the national level, its results may be observed in public health. The first one is a good compliance of women, i.e. the proportion of women aged 20–64 who had at least one PAP smear taken in a three-year period which is the recommended screening interval in our country. In the last three years (2006–2008), the compliance was 71.2%. Looking at five years, which is the screening interval in Finland and in Great Britain, the compliance is 82.1%. In Britain, in the same period, the compliance was 78.6%, and in Finland, it has not exceeded 70% for several years. The second public health result is a smaller number of new cervical cancer cases. In five years, the cervical cancer incidence decreased by more than a quarter (28%). In 2003, 209 new cases were registered in the Cancer Registry of Republic of Slovenia, while in 2007, there were 151 new cases. In 2007, 260.684 smears from 235.713 women were registered in the Screening Registry. Altogether 194.163 women (82%) attended screening examination, while others were coming for follow-up or had clinical symptoms. In the histology registry, 8.569 exams were registered; more than half were made for diagnostic purposes. It would certainly be difficult to achieve such good results without great endeavors of all gynecologists at primary health care level, all screeners and cytopathologists in all Slovenian laboratories and all other experts involved in multidisciplinary process of screening, diagnostics and treatment. Their good collaboration in achieving further progress is greatly appreciated.

Archive

niGradiv

Back